DGX
Quest Diagnostics Incorporated
NYSE · Healthcare · Medical - Diagnostics & Research · US
$237.58
−0.76%Forward multiples
Based on analyst estimates
- P/E forward
- 20.72x
- P/E 2026E
- 21.19x
- P/E 2027E
- 19.67x
- P/E 2028E
- 18.11x
- P/S forward
- 2.14x
Trailing multiples
Trailing twelve months
- P/E TTM
- 24.90x
- PEG TTM
- 1.23x
- Price / book
- 3.49x
- Price / sales
- 2.27x
- Price / cash flow
- 14.78x
Enterprise value
- Enterprise value
- $32.3B
- EV / sales
- 2.79x
- EV / EBITDA
- 16.08x
- EV / EBIT
- 19.74x
- Market cap
- $26.2B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026